학술논문

1094P The clinical potential of circulating-free DNA (cfDNA) for real-time longitudinally monitoring clinical outcomes in a real-world first-line non-small cell lung cancer (NSCLC) prospective study
Document Type
Abstract
Source
In Annals of Oncology September 2022 33 Supplement 7:S1051-S1051
Subject
Language
ISSN
0923-7534